Loading clinical trials...
Loading clinical trials...
The primary objective of the study is to evaluate belumosudil pharmacokinetics of whole tablets and crushed tablets suspended in water in patients suffering from chronic graft-versus-host disease (cGV...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
M.D. Anderson Cancer Center
NCT04431479 · Chronic Graft Versus Host Disease
NCT01804686 · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and more
NCT06271616 · Chronic Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm
NCT06247150 · Chronic Graft Versus Host Disease
NCT00637689 · Chronic Graft Versus Host Disease
The University of Texas M. D. Anderson Cancer Center
Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions